Ganeden

Ganeden is a prominent biotechnology company focused on the development of probiotic ingredients for the global functional food, beverage, and dietary supplement industries. The company's flagship technology is GanedenBC30, a patented, spore-forming probiotic strain (Bacillus coagulans GBI-30, 6086) known for its exceptional stability and ability to survive extreme temperatures and manufacturing processes. Beyond digestive health, Ganeden has expanded its portfolio to include immune health ingredients like Staimune. In 2017, the company was acquired by Kerry Group, integrating its extensive intellectual property and clinical research into Kerry's nutrition and wellness division. Ganeden's ingredients are currently featured in over 1,000 consumer products worldwide, supported by more than 25 published clinical studies.